2017 annual financial data
Alnylam Pharmaceuticals 2017 Financial results
Direct answer
Revenue was 89.91M USD.
Operating income was -500.09M USD and net income was -490.87M USD.
Operating cash flow was -382.79M USD.
Get free Alnylam Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 89.91M USD
- Operating income
- -500.09M USD
- Net income
- -490.87M USD
- Operating cash flow
- -382.79M USD
Explore related company data
View all 2017 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Net marginView Operating cash flow marginView all Alnylam Pharmaceuticals financial years